SCHEMBL6355358

SCHEMBL6355358

O=C(Nc1ccc(Br)cc1C(=O)O)c1ccc(Br)c(S(=O)(=O)NC2Cc3ccccc3C2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.53
KMT2A Q03164 4/20 0.53
ALDH1A1 P00352 1/20 0.53
PTGES O14684 1/20 0.52
ALOX5 P09917 1/20 0.52
AKR1C2 P52895 3/20 0.50
AKR1C1 Q04828 3/20 0.50
AKR1C4 P17516 1/20 0.50
AKR1C3 P42330 1/20 0.50
PPARG P37231 1/20 0.49
PPARD Q03181 1/20 0.49
PPARA Q07869 1/20 0.49
RPA1 P27694 1/20 0.47
GFER P55789 1/20 0.47
DHODH Q02127 1/20 0.47
ALB P02768 1/20 0.46
MAPT P10636 4/20 0.46
TP53 P04637 2/20 0.46
ABL1 P00519 1/20 0.45
TSHR P16473 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6357975 0.91 MEN1 (0.64) MEN1KMT2AALDH1A1PTGESALOX5
SCHEMBL6352363 0.88 MAPT (0.52) MEN1KMT2AALDH1A1AKR1C2AKR1C1
SCHEMBL6351288 0.87 PPARG (0.52) MEN1KMT2AAKR1C2AKR1C1AKR1C4
SCHEMBL6350870 0.85 PPARG (0.61) MEN1KMT2AAKR1C2AKR1C1AKR1C4
SCHEMBL6351026 0.83 LMNA (0.51) MEN1KMT2AAKR1C2AKR1C1AKR1C4
SCHEMBL6833361 0.83 PPARG (0.49) MEN1KMT2AAKR1C2AKR1C1AKR1C4
SCHEMBL6834099 0.81 PRSS12 (0.42) MEN1KMT2APTGESALOX5AKR1C2
SCHEMBL6833903 0.80 MEN1 (0.42) MEN1KMT2AAKR1C2AKR1C1AKR1C4
SCHEMBL4103906 0.79 PTGES (0.69) MEN1KMT2AALDH1A1PTGESALOX5
SCHEMBL6353643 0.78 LMNA (0.49) MEN1KMT2AAKR1C2AKR1C1AKR1C4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed
WO-2004018414-A2 ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 MEN1 3274/4885KMT2A 3645/4885ALDH1A1 462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.